A
8.47
0.32 (3.93%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Aspire-Lakewood Holdings, Inc. | - | - |
AIStockmoo 评分
-0.2
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.5 |
| 平均 | -0.21 |
|
Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 33.08% |
| 机构持股比例 | 4.16% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Antara Capital Lp | 31 Dec 2025 | 169 |
| Valley Wealth Managers, Inc. | 30 Jun 2026 | 33 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合